Analysis of samples from completed PsiOxus sponsored clinical trials
Research type
Research Study
Full title
Analysis of patient samples from completed PsiOxus clinical trials to aid in understanding of drug mechanism of action and to develop assays for future use
IRAS ID
287283
Contact name
David Krige
Contact email
Sponsor organisation
PsiOxus Therapeutics Ltd
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
The study will analyse samples obtained from clinical trials in oncology to develop knowledge of the mechanism of action of the investigational product and also to improve methods for the analysis of samples. The research will include blood and urine samples and tumour tissue from PsiOxus sponsored clinical trials. There is no direct benefit to the patients that participated in the trials but this study may help understand the mechanism of action of the investigational product and will support future studies to ensure that samples obtained are used efficiently and effectively.
REC name
South Central - Oxford C Research Ethics Committee
REC reference
20/SC/0454
Date of REC Opinion
21 Dec 2020
REC opinion
Favourable Opinion